Business Focus Shift - The company plans to shift its focus and resources from the health business to the electronic components business due to higher performance and growth potential in the latter[7]. - The health business primarily involves the procurement and wholesale of health products, including ginseng and skincare products, supported by a professional team with over 10 years of experience[10]. - The company is actively exploring potential collaborations with a major online retail platform in China to supply health products, which may enhance brand promotion and business outreach[13]. Electronic Components Business - The electronic components business was launched in July 2019, following a significant acquisition by the chairman, which has since established a global trading network for electronic components[3]. - The sales team has over 20 years of experience in the electronic components industry, enabling the company to procure high-quality products at reasonable prices[4]. - The company has established long-term relationships with over 20 customers and suppliers, primarily in the electronic components sector[4]. - The company plans to recruit more engineers and sales personnel to support the growth of the electronic components business[8]. - The company aims to expand its electronic components business through various strategies outlined in its mid-year report[8]. - The sales team regularly communicates with suppliers and customers to stay updated on market trends and demand[5]. Health Business Relationships - The health business maintains stable relationships with over 10 suppliers and customers, primarily in Hong Kong and China[11]. - The company is conducting site visits to manufacturers in Taiwan and Thailand to explore procurement of new health products and establish authorized distribution relationships[17]. Financial Prepayments - As of February 28, 2022, the total prepayment made to Jingdong E-Commerce was approximately HKD 60.5 million, representing about 8.0% of the company's total assets[20]. - By March 9, 2022, the total prepayment increased to approximately HKD 84.0 million, accounting for about 11.2% of total assets, reflecting a 3.2% increase[20]. - On March 22, 2022, the prepayment rose to approximately HKD 106.7 million, which was about 14.2% of total assets, showing a 3.0% increase[20]. - By March 25, 2022, the prepayment reached approximately HKD 169.1 million, representing about 22.5% of total assets, with an 8.3% increase from the previous amount[20]. - As of June 8, 2022, the prepayment totaled approximately HKD 212.4 million, accounting for about 28.8% of total assets, indicating a 6.3% increase[20]. - On June 17, 2022, the prepayment further increased to approximately HKD 245.0 million, which was about 33.2% of total assets, reflecting a 4.4% increase[22]. - By July 14, 2022, the prepayment reached approximately HKD 272.0 million, representing about 36.8% of total assets, with a 3.6% increase[22]. Investment Opportunities - The company is in discussions for a potential investment opportunity in a food processing and raw material extraction factory in Taiwan, aimed at creating synergies and gaining deeper market insights[14][16]. - The company will continue to review its business activities and assets to create greater value for shareholders[7].
前海健康(00911) - 2022 Q3 - 季度财报